Phase I trials on the rise in New Zealand

3rd January 2018 (Last Updated January 3rd, 2018 11:11)

GlobalData has compiled a summary of clinical trials in New Zealand. GlobalData captured records of 1,016 clinical trials across all diseases and phases that had a start date between 1 January 2012 and 31 December 2016.

GlobalData has compiled a summary of clinical trials in New Zealand. GlobalData captured records of 1,016 clinical trials across all diseases and phases that had a start date between 1 January 2012 and 31 December 2016.

In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively. Overall, Phase III trials outnumbered all other trials, making up 40–48% of the trial types across the period. The share of Phase II trials was second, ranging from 24–39%, and hitting its lowest percentage in 2014, as shown in Figure 1. The share of Phase I trials increased from 10% up to 26% over the five-year period, while Phase IV trials decreased from 13% in 2012 to 5% in 2016.

Figure 1: clinical trials in New Zealand by phase, 2012-2016

Source: GlobalData Pharma Intelligence Center, Clinical Trials Database [Accessed December, 2017]